InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,788.29
(
-0.01%
)
Post# of 8463
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

imapro

Send PM Follow Ignore
Followers 100
Posts 2884
Boards Moderated 0
Alias Born 12/08/2012

imapro

Re: None

Tuesday, 09/26/2017 11:32:36 AM

Tuesday, September 26, 2017 11:32:36 AM

Post# of 8463
NVAX Conference key takeaways
RSV VACCINE
-Novavax is the leader in RSV vaccine development
-$89 million grant from Bill and Melinda Gates foundation
-Interim data analysis in 2018
DIFFERENTIATED NANOFLU VACCINE
-Nanoflu phase 1/2 trials underway
-FDA meeting for possible accelerated approval in early 2018
-Nanoflu pivotal phase 3 immunogenicity trial date late 2018
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NVAX News
More NVAX News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!